ALK c.3895G>C ;(p.E1299Q)

Variant ID: 2-29430080-C-G

NM_004304.4(ALK):c.3895G>C;(p.E1299Q)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Molecular matching and treatment strategies for advanced stage lung cancer at Dartmouth-Hitchcock Medical Center: A three-year review of a Molecular Tumor Board.

Practical Laboratory Medicine
Bernhardt, Erica B EB; Chamberlin, Mary D MD; Gorlov, Ivan P IP; de Abreu, Francine B FB; Bloch, Katarzyna J KJ; Peterson, Jason D JD; Tsongalis, Gregory J GJ; Shirai, Keisuke K; Dragnev, Konstantin H KH; Miller, Todd W TW; Tafe, Laura J LJ
Publication Date: 2020-08

Variant appearance in text: ALK: E1299Q
PubMed Link: 32613070
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



KRAS mutation is predictive of outcome in patients with pulmonary sarcomatoid carcinoma.

Histopathology
Mehrad, Mitra M; Roy, Somak S; LaFramboise, William A WA; Petrosko, Patti P; Miller, Caitlyn C; Incharoen, Pimpin P; Dacic, Sanja S
Publication Date: 2018-08

Variant appearance in text: ALK: E1299Q
PubMed Link: 29489023
Variant Present in the following documents:
  • Main text
View BVdb publication page